Literature DB >> 27899621

Cooperative genomic alteration network reveals molecular classification across 12 major cancer types.

Hongyi Zhang1, Yulan Deng1, Yong Zhang1, Yanyan Ping1, Hongying Zhao1, Lin Pang1, Xinxin Zhang1, Li Wang1, Chaohan Xu1, Yun Xiao2, Xia Li3.   

Abstract

The accumulation of somatic genomic alterations that enables cells to gradually acquire growth advantage contributes to tumor development. This has the important implication of the widespread existence of cooperative genomic alterations in the accumulation process. Here, we proposed a computational method HCOC that simultaneously consider genetic context and downstream functional effects on cancer hallmarks to uncover somatic cooperative events in human cancers. Applying our method to 12 TCGA cancer types, we totally identified 1199 cooperative events with high heterogeneity across human cancers, and then constructed a pan-cancer cooperative alteration network. These cooperative events are associated with genomic alterations of some high-confident cancer drivers, and can trigger the dysfunction of hallmark associated pathways in a co-defect way rather than single alterations. We found that these cooperative events can be used to produce a prognostic classification that can provide complementary information with tissue-of-origin. In a further case study of glioblastoma, using 23 cooperative events identified, we stratified patients into molecularly relevant subtypes with a prognostic significance independent of the Glioma-CpG Island Methylator Phenotype (GCIMP). In summary, our method can be effectively used to discover cancer-driving cooperative events that can be valuable clinical markers for patient stratification. © Crown copyright 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27899621      PMCID: PMC5314758          DOI: 10.1093/nar/gkw1087

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  77 in total

1.  Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.

Authors:  Jing Wang; Yang Zhang; Xiaopei Shen; Jing Zhu; Lin Zhang; Jinfeng Zou; Zheng Guo
Journal:  Mol Biosyst       Date:  2011-01-28

2.  A mathematical framework to determine the temporal sequence of somatic genetic events in cancer.

Authors:  Camille Stephan-Otto Attolini; Yu-Kang Cheng; Rameen Beroukhim; Gad Getz; Omar Abdel-Wahab; Ross L Levine; Ingo K Mellinghoff; Franziska Michor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-23       Impact factor: 11.205

3.  Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.

Authors:  Zhi-yong Huang; Rebecca L Baldwin; Nicolé M Hedrick; David H Gutmann
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

4.  Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.

Authors:  Lionel M L Chow; Raelene Endersby; Xiaoyan Zhu; Sherri Rankin; Chunxu Qu; Junyuan Zhang; Alberto Broniscer; David W Ellison; Suzanne J Baker
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

5.  A network model of a cooperative genetic landscape in brain tumors.

Authors:  Markus Bredel; Denise M Scholtens; Griffith R Harsh; Claudia Bredel; James P Chandler; Jaclyn J Renfrow; Ajay K Yadav; Hannes Vogel; Adrienne C Scheck; Robert Tibshirani; Branimir I Sikic
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

6.  IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals.

Authors:  Yanyan Ping; Hongyi Zhang; Yulan Deng; Li Wang; Hongying Zhao; Lin Pang; Huihui Fan; Chaohan Xu; Feng Li; Yong Zhang; Yonghui Gong; Yun Xiao; Xia Li
Journal:  Mol Biosyst       Date:  2014-08

7.  Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.

Authors:  Iñigo Martincorena; Amit Roshan; Moritz Gerstung; Peter Ellis; Peter Van Loo; Stuart McLaren; David C Wedge; Anthony Fullam; Ludmil B Alexandrov; Jose M Tubio; Lucy Stebbings; Andrew Menzies; Sara Widaa; Michael R Stratton; Philip H Jones; Peter J Campbell
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

Review 8.  The DNA damage response and cancer therapy.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 9.  In Vitro Maturation in Women with vs. without Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Charalampos Siristatidis; Theodoros N Sergentanis; Paraskevi Vogiatzi; Prodromos Kanavidis; Charalampos Chrelias; Nikolaos Papantoniou; Theodora Psaltopoulou
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

10.  An epistatic ratchet constrains the direction of glucocorticoid receptor evolution.

Authors:  Jamie T Bridgham; Eric A Ortlund; Joseph W Thornton
Journal:  Nature       Date:  2009-09-24       Impact factor: 49.962

View more
  14 in total

1.  Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis.

Authors:  Wubin Ding; Geng Chen; Tieliu Shi
Journal:  Epigenetics       Date:  2019-01-29       Impact factor: 4.528

2.  Identifying prognostic signature in ovarian cancer using DirGenerank.

Authors:  Jian-Yong Wang; Ling-Ling Chen; Xiong-Hui Zhou
Journal:  Oncotarget       Date:  2017-07-11

3.  A pan-cancer atlas of cancer hallmark-associated candidate driver lncRNAs.

Authors:  Yulan Deng; Shangyi Luo; Xinxin Zhang; Chaoxia Zou; Huating Yuan; Gaoming Liao; Liwen Xu; Chunyu Deng; Yujia Lan; Tingting Zhao; Xu Gao; Yun Xiao; Xia Li
Journal:  Mol Oncol       Date:  2018-10-02       Impact factor: 6.603

4.  DNMIVD: DNA methylation interactive visualization database.

Authors:  Wubin Ding; Jiwei Chen; Guoshuang Feng; Geng Chen; Jun Wu; Yongli Guo; Xin Ni; Tieliu Shi
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

5.  Transcriptomic heterogeneity of driver gene mutations reveals novel mutual exclusivity and improves exploration of functional associations.

Authors:  Yujia Lan; Wei Liu; Wanmei Zhang; Jing Hu; Xiaojing Zhu; Linyun Wan; Suru A; Yanyan Ping; Yun Xiao
Journal:  Cancer Med       Date:  2021-06-02       Impact factor: 4.452

6.  SEECancer: a resource for somatic events in evolution of cancer genome.

Authors:  Hongyi Zhang; Shangyi Luo; Xinxin Zhang; Jianlong Liao; Fei Quan; Erjie Zhao; Chenfen Zhou; Fulong Yu; Wenkang Yin; Yunpeng Zhang; Yun Xiao; Xia Li
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

7.  Genome-wide methylation patterns predict clinical benefit of immunotherapy in lung cancer.

Authors:  Jeong Yeon Kim; Jung Kyoon Choi; Hyunchul Jung
Journal:  Clin Epigenetics       Date:  2020-08-06       Impact factor: 6.551

8.  Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.

Authors:  Yanjun Xu; Qun Dong; Feng Li; Yingqi Xu; Congxue Hu; Jingwen Wang; Desi Shang; Xuan Zheng; Haixiu Yang; Chunlong Zhang; Mengting Shao; Mohan Meng; Zhiying Xiong; Xia Li; Yunpeng Zhang
Journal:  J Transl Med       Date:  2019-08-06       Impact factor: 5.531

9.  Co-occurrence and Mutual Exclusivity Analysis of DNA Methylation Reveals Distinct Subtypes in Multiple Cancers.

Authors:  Wubin Ding; Guoshuang Feng; Yige Hu; Geng Chen; Tieliu Shi
Journal:  Front Cell Dev Biol       Date:  2020-01-29

10.  The correlation and role analysis of COL4A1 and COL4A2 in hepatocarcinogenesis.

Authors:  Yanli Liu; Jiaye Zhang; Yan Chen; Hasan Sohel; Xinrong Ke; Jingqi Chen; Yin-Xiong Li
Journal:  Aging (Albany NY)       Date:  2020-01-05       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.